MRM (MEDIROM Healthcare Technologies) Research & Development: $0.00 Mil (TTM As of Jun. 2025)


MRM MEDIROM Healthcare Technologies Inc MRM
53 GF Score
Price $1.07
GF Value $4.08
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is MEDIROM Healthcare Technologies Research & Development?

MEDIROM Healthcare Technologies MRM -4.43% 53 Research & Development is $0.00 Mil as of Jun. 2025. GuruFocus rates MRM with a GF Score™ of 53/100 and a GF Value™ of $4.08 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. MEDIROM Healthcare Technologies's Research & Development for the six months ended in Jun. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00 Mil.

MEDIROM Healthcare Technologies  (NAS:MRM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MEDIROM Healthcare Technologies Research & Development Related Terms

MEDIROM Healthcare Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for MEDIROM Healthcare Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDIROM Healthcare Technologies Research & Development Chart

MEDIROM Healthcare Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

MEDIROM Healthcare Technologies Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MRM
53GF Score
MEDIROM Healthcare Technologies Inc MRM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDIROM Healthcare Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
MEDIROM Healthcare Technologies (MRM) has a Research & Development of $0.00 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on MEDIROM Healthcare Technologies and its competitors.
Is MEDIROM Healthcare Technologies' Research & Development too high?
MEDIROM Healthcare Technologies' current Research & Development is $0.00 Mil. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' Research & Development compare to DROR and CLIK?
MEDIROM Healthcare Technologies' Research & Development of $0.00 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Personal Services company?
A good Research & Development depends on the Personal Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on MEDIROM Healthcare Technologies and its competitors. MEDIROM Healthcare Technologies's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.08, compared to a current price of $1.07 — trading 73.8% below its estimated fair value. The current Research & Development is $0.00 Mil. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current Research & Development is $0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?

Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued. The current stock price of $1.07 is trading 73.8% below its estimated GF Value™ of $4.08. GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.

Key valuation signals for MRM:

  • Research & Development: $0.00 Mil
  • GF Value™: $4.08 vs. price of $1.07 (73.8% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDIROM Healthcare Technologies Business Description

Address 2-3-1 Daiba, 16th Floor, Tradepia Odaiba, Minato-ku, Tokyo, JPN, 135-0091
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score

Get the complete analysis for MRM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price
$4.08
GF Value